Sarepta Therapeutics, Inc. (SRPT)
21.72
-1.31
(-5.69%)
USD |
NASDAQ |
May 07, 09:54
Sarepta Therapeutics SG&A Expense (TTM) : 491.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| PTC Therapeutics, Inc. | 347.14M |
| Keros Therapeutics, Inc. | 46.85M |
| REGENXBIO, Inc. | 82.86M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| Arrowhead Pharmaceuticals, Inc. | 143.05M |